Evidence for the involvement of epigenetics in the progression of renal fibrogenesis
mTOR controls kidney epithelia in health and disease
The Nrf2 pathway in the progression of renal disease
Proteasome inhibitors in progressive renal diseases
A perspective on anti-CCN2 therapy for chronic kidney disease
Transforming growth factor-β and the progression of renal disease
PDGF and the progression of renal disease
TWEAK and the progression of renal disease
Aldosterone synthase inhibitors in cardiovascular and renal diseases
Endothelin antagonism for patients with chronic kidney disease
Sulodexide and glycosaminoglycans in the progression of renal disease